Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | — | 789† | 714† | 527† | 525† |
| Net profit | 88 | 68 | 49 | 4 | 68† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Ramesh Babu Potluri | Executive Director | June 30, 2026 |
| Vamsi Krishna Potluri | Executive Director | June 30, 2026 |
| Sarvepalli Srinivas | Independent Director | June 30, 2026 |
| Shanti Sree Bolleni | Independent Director | June 30, 2026 |
| Shravan Kudaravalli | Independent Director | June 30, 2026 |
| Suresh Kumar Gangavarapu | Independent Director | June 30, 2026 |
| Sunkara Venkata Satya Shiva Prasad | Non-Executive Director | June 30, 2026 |
| Trilok Potluri | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
